Celltrion Views Brazilian Approval As Gateway Into Latin America
• By Aidan Fry
Celltrion is looking to use its approval for biosimilar trastuzumab in Brazil as a base from whicht to expand in Central and South America • Source: Shutterstock
Stay ahead of every shift in generics and biosimilars.
Generics Bulletin brings you the latest updates that matter for the off-patent industry.
